Abstract
The central effects of propranolol, a lipophilic beta-adrenoceptor antagonist, were investigated in six healthy male volunteers using two flash fusion threshold (2FFT), simple reaction time (SRT), digital copying test (DCT), symbol digit modalities test (SDMT), Gibson spiral maze test (GSMT) and mood rating scales for tension, alertness, depression, detachment and anxiety. Compared to placebo, 2FFT was prolonged by propranolol 40, 80 and 160 mg at one or more times tested but not by propranolol 320 mg: the largest effect was seen at 3 h after 40 mg, and the effects of 40, 80 and 160 mg were significantly greater than 320 mg at 2 h. SRTs were significantly prolonged by all doses of propranolol at 2 and 3 h and by 40 and 80 mg doses at 5 h. DCT was lowered by 40 and 80 mg at 2 and 3 h by 80 mg at 5 h, and by 320 mg at 2 h, but the 160 mg dose had no effect. Propranolol impaired the expected retest gain of the SDMT with all doses except 320 mg and at 2 h after 40, 80 and 160 mg, performance was actually worsened. Mood rating scales showed increased detachment with 40 mg and decreased alertness with 80 and 320 mg. The results show that propranolol has central effects in man: the effects appeared to be greater with lower doses, 40 and 80 mg, than with higher doses, 160 and 320 mg.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashton H., Millman J. E., Telford R., Thompson J. W. A comparison of some physiological and psychological effects of Motival (fluphenazine and nortriptyline) and diazepam in normal subjects. Br J Clin Pharmacol. 1978 Feb;5(2):141–147. doi: 10.1111/j.1365-2125.1978.tb01615.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol. 1980 Sep;10(3):189–209. doi: 10.1111/j.1365-2125.1980.tb01745.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landauer A. A., Pocock D. A., Prott F. W. Effects of atenolol and propranolol on human performance and subjective feelings. Psychopharmacology (Berl) 1979 Jan 31;60(2):211–215. doi: 10.1007/BF00432296. [DOI] [PubMed] [Google Scholar]
- McDevitt D. G. Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Drugs. 1979 Apr;17(4):267–288. doi: 10.2165/00003495-197917040-00002. [DOI] [PubMed] [Google Scholar]
- Neil-Dwyer G., Bartlett J., McAinsh J., Cruickshank J. M. Beta-adrenoceptor blockers and the blood-brian barrier. Br J Clin Pharmacol. 1981 Jun;11(6):549–553. doi: 10.1111/j.1365-2125.1981.tb01169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ogle C. W., Turner P., Markomihelakis H. The effects of high doses of oxprenolol and of propranolol on pursuit rotor performance, reaction time and critical flicker frequency. Psychopharmacologia. 1976 Apr 15;46(3):295–299. doi: 10.1007/BF00421117. [DOI] [PubMed] [Google Scholar]
- Salem S. A., McDevitt D. G. Central effects of beta-adrenoceptor antagonists. Clin Pharmacol Ther. 1983 Jan;33(1):52–57. doi: 10.1038/clpt.1983.7. [DOI] [PubMed] [Google Scholar]
- Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]